FDA approves first imaging agent for MR angiography in U.S.

January 7, 2009 FDA approves first imaging agent for MR angiography in U.S. By Rebekah Moan -------------------------------------------------------------------------------- After prolonged deliberation and repeated demands for more research, the FDA has approved Vasovist (gadofosveset trisodium), the first contrast imaging agent to gain regulatory clearance specifically for MR angiography. The agency approved the New Drug Application for Vasovist on Dec. 24. Epix Pharmaceuticals, the agent's developer in Lexington, MA, welcomed the announcement.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC